Antiviral Medications and CYP3A4/P-glycoprotein Interactions: What You Need to Know
January 15, 2026 by Maxwell Harrington
CYP3A4 and P-glycoprotein interactions can make or break antiviral therapy. Learn how ritonavir, cobicistat, and newer DAAs affect drug levels, what medications to avoid, and how to prevent dangerous side effects.